🔗 Share this article

An underground economy for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to message these accounts privately for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, administration instructions and claims of next-day British shipping. Vendors market the substance there before redirecting customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Healthcare Professionals Express Concerns

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could lead to users injecting substances of uncertain source.

Some experts stated the popularity for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Some content creators try to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or imprisonment.

Service Response and Content Elimination

According to the social media company, the service has removed problematic material and prohibited associated keywords and query recommendations. The organization stated it was committed to maintaining the platform secure and allocating resources in strengthening enforcement strategies.

Digital Trading Operations

Investigations also discovered groups with up to nine thousand participants selling the experimental drug using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with photos of weight loss, glowing reviews and detailed instructions for preparing or administering at residence.

After minutes of joining one community, a seller posted contact information, where most purchases take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about body mass, health issues or previous experience.

Product Information and Pricing

Within these communities, posts show black plastic packages with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her staff has already encountered individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may subject patients to potentially significant medical dangers”.